Screener
Polaryx Therapeutics, Inc. PLYX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Polaryx Therapeutics, Inc.’s 10-Q, filed May 15, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-056973
FAQ
- What is Polaryx Therapeutics, Inc.'s EPS (diluted)?
- Polaryx Therapeutics, Inc. (PLYX) reported EPS (diluted) of -$0.05 in Q1 2026.
- How has Polaryx Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Polaryx Therapeutics, Inc.'s EPS (diluted) increased by 54.5% year-over-year, from -$0.11 to -$0.05.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Polaryx Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude